Terms: = Endocrine gland cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC
20 results:
1. The value of deep neural networks in the pathological classification of thyroid tumors.
Deng C; Li D; Feng M; Han D; Huang Q
Diagn Pathol; 2023 Aug; 18(1):95. PubMed ID: 37598149
[TBL] [Abstract] [Full Text] [Related]
2. Thyroid cancer: The Quest for Genetic Susceptibility Involving DNA Repair Genes.
Santos LS; Gomes BC; Bastos HN; Gil OM; Azevedo AP; Ferreira TC; Limbert E; Silva SN; Rueff J
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31374908
[TBL] [Abstract] [Full Text] [Related]
3. Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer.
Ishibashi M; Toyoshima M; Zhang X; Hasegawa-Minato J; Shigeta S; Usui T; Kemp CJ; Grandori C; Kitatani K; Yaegashi N
Sci Rep; 2018 Sep; 8(1):13207. PubMed ID: 30181600
[TBL] [Abstract] [Full Text] [Related]
4. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.
Zhao Z; Zhang A; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Li J; Duan P
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29669843
[TBL] [Abstract] [Full Text] [Related]
5. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.
Zhao F; Shang Y; Zeng C; Gao D; Li K
Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894
[TBL] [Abstract] [Full Text] [Related]
6. eIF3a improve cisplatin sensitivity in ovarian cancer by regulating xpc and p27Kip1 translation.
Zhang Y; Yu JJ; Tian Y; Li ZZ; Zhang CY; Zhang SF; Cao LQ; Zhang Y; Qian CY; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2015 Sep; 6(28):25441-51. PubMed ID: 26213845
[TBL] [Abstract] [Full Text] [Related]
7. The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer.
Santos LS; Gomes BC; Gouveia R; Silva SN; Azevedo AP; Camacho V; Manita I; Gil OM; Ferreira TC; Limbert E; Rueff J; Gaspar JF
Oncol Rep; 2013 Nov; 30(5):2458-66. PubMed ID: 23982724
[TBL] [Abstract] [Full Text] [Related]
8. DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy.
Kang S; Sun HY; Zhou RM; Wang N; Hu P; Li Y
Asian Pac J Cancer Prev; 2013; 14(2):941-6. PubMed ID: 23621265
[TBL] [Abstract] [Full Text] [Related]
9. Unexpected extradermatological findings in 31 patients with xeroderma pigmentosum type C.
Hadj-Rabia S; Oriot D; Soufir N; Dufresne H; Bourrat E; Mallet S; Poulhalon N; Ezzedine K; Grandchamp B; Taïeb A; Catteau B; Sarasin A; Bodemer C
Br J Dermatol; 2013 May; 168(5):1109-13. PubMed ID: 23278166
[TBL] [Abstract] [Full Text] [Related]
10. Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses.
Muenyi CS; Pinhas AR; Fan TW; Brock GN; Helm CW; States JC
Toxicol Sci; 2012 May; 127(1):139-49. PubMed ID: 22331493
[TBL] [Abstract] [Full Text] [Related]
11. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract] [Full Text] [Related]
12. Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer.
Duell EJ; Bracci PM; Moore JH; Burk RD; Kelsey KT; Holly EA
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1470-9. PubMed ID: 18559563
[TBL] [Abstract] [Full Text] [Related]
13. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk.
McWilliams RR; Bamlet WR; Cunningham JM; Goode EL; de Andrade M; Boardman LA; Petersen GM
Cancer Res; 2008 Jun; 68(12):4928-35. PubMed ID: 18544627
[TBL] [Abstract] [Full Text] [Related]
14. Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients.
Saldivar JS; Lu KH; Liang D; Gu J; Huang M; Vlastos AT; Follen M; Wu X
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S223-9. PubMed ID: 17825393
[TBL] [Abstract] [Full Text] [Related]
15. [Polymorphisms of the DNA repair genes XRCC1 and xpc: relationship to pancreatic cancer risk].
Wang L; Lin DX; Lu XH; Miao XP; Li H
Wei Sheng Yan Jiu; 2006 Sep; 35(5):534-6. PubMed ID: 17086695
[TBL] [Abstract] [Full Text] [Related]
16. Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines.
Peters GJ; Van Moorsel CJ; Lakerveld B; Smid K; Noordhuis P; Comijn EC; Weaver D; Willey JC; Voorn D; Van der Vijgh WJ; Pinedo HM
Int J Oncol; 2006 Jan; 28(1):237-44. PubMed ID: 16328001
[TBL] [Abstract] [Full Text] [Related]
17. Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors.
Takebayashi Y; Nakayama K; Kanzaki A; Miyashita H; Ogura O; Mori S; Mutoh M; Miyazaki K; Fukumoto M; Pommier Y
Cancer Lett; 2001 Dec; 174(2):115-25. PubMed ID: 11689286
[TBL] [Abstract] [Full Text] [Related]
18. Mutational inactivation of the xeroderma pigmentosum group C gene confers predisposition to 2-acetylaminofluorene-induced liver and lung cancer and to spontaneous testicular cancer in Trp53-/- mice.
Cheo DL; Burns DK; Meira LB; Houle JF; Friedberg EC
Cancer Res; 1999 Feb; 59(4):771-5. PubMed ID: 10029060
[TBL] [Abstract] [Full Text] [Related]
19. Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines.
Damia G; Guidi G; D'Incalci M
Eur J Cancer; 1998 Oct; 34(11):1783-8. PubMed ID: 9893669
[TBL] [Abstract] [Full Text] [Related]
20. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
[TBL] [Abstract] [Full Text] [Related]
